Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,510 | 1,065 | 99.8% |
| Education | $27.68 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,059 | 101 | $0 (2024) |
| Lilly USA, LLC | $1,763 | 154 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,500 | 146 | $0 (2024) |
| Novo Nordisk Inc | $1,353 | 127 | $0 (2024) |
| PFIZER INC. | $878.70 | 90 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $770.59 | 65 | $0 (2024) |
| Amgen Inc. | $704.81 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $657.50 | 83 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $648.57 | 48 | $0 (2022) |
| ABBVIE INC. | $596.00 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,281 | 74 | Lilly USA, LLC ($357.87) |
| 2023 | $1,171 | 74 | GlaxoSmithKline, LLC. ($304.71) |
| 2022 | $1,652 | 118 | Lilly USA, LLC ($229.28) |
| 2021 | $1,763 | 125 | Novo Nordisk Inc ($228.44) |
| 2020 | $1,075 | 67 | AstraZeneca Pharmaceuticals LP ($316.88) |
| 2019 | $1,970 | 182 | AstraZeneca Pharmaceuticals LP ($369.43) |
| 2018 | $2,313 | 224 | AstraZeneca Pharmaceuticals LP ($411.37) |
| 2017 | $2,313 | 204 | AstraZeneca Pharmaceuticals LP ($416.31) |
All Payment Transactions
1,068 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), VAXELIS, BEYFORTUS | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Vaccines | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: PAIN | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.27 | General |
| Category: Endovascular | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: VACCINES | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 522 | 720 | $118,859 | $53,431 |
| 2022 | 7 | 453 | 624 | $100,197 | $48,292 |
| 2021 | 10 | 607 | 817 | $94,752 | $47,790 |
| 2020 | 8 | 646 | 916 | $92,113 | $42,220 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 227 | $41,768 | $18,355 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $37,942 | $14,971 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 174 | $22,446 | $10,251 | 45.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 54 | 54 | $5,124 | $3,881 | 75.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,348 | $3,380 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $2,460 | $1,721 | 70.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $533.00 | $372.84 | 70.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 29 | $1,334 | $239.66 | 18.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 17 | $748.00 | $234.01 | 31.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $156.00 | $26.40 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 186 | $34,224 | $15,167 | 44.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $26,577 | $12,736 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 203 | $26,187 | $11,963 | 45.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 50 | $4,438 | $3,407 | 76.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $5,819 | $3,059 | 52.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 51 | 55 | $2,255 | $1,496 | 66.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $697.00 | $464.12 | 66.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 244 | $29,164 | $14,155 | 48.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 175 | $30,699 | $13,653 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 102 | 102 | $21,012 | $12,978 | 61.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 72 | 73 | $6,351 | $4,760 | 74.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 67 | 68 | $2,788 | $1,070 | 38.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 14 | $1,904 | $524.42 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 71 | 91 | $1,092 | $273.00 | 25.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 19 | $874.00 | $194.23 | 22.2% |
About Dr. Patrick Garrison, MD
Dr. Patrick Garrison, MD is a Pediatrics healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598806663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Garrison, MD has received a total of $13,538 in payments from pharmaceutical and medical device companies, with $1,281 received in 2024. These payments were reported across 1,068 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,510).
As a Medicare-enrolled provider, Garrison has provided services to 2,228 Medicare beneficiaries, totaling 3,077 services with total Medicare billing of $191,733. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Oklahoma City, OK
- Active Since 02/09/2007
- Last Updated 05/20/2014
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1598806663
Products in Payments
- FARXIGA (Drug) $1,325
- JARDIANCE (Drug) $943.51
- MOUNJARO (Drug) $645.54
- TRELEGY ELLIPTA (Drug) $640.52
- TRULICITY (Drug) $605.41
- Ozempic (Drug) $479.09
- JANUVIA (Drug) $421.35
- SYMBICORT (Drug) $347.21
- Aimovig (Biological) $334.29
- NURTEC ODT (Drug) $292.73
- ANORO (Drug) $284.67
- TRINTELLIX (Drug) $279.36
- EUCRISA (Drug) $232.97
- BREO (Drug) $231.54
- TOUJEO (Drug) $215.19
- SHINGRIX (Biological) $210.48
- Saxenda (Drug) $205.24
- Victoza (Drug) $203.10
- Prolia (Biological) $190.70
- VRAYLAR (Drug) $180.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Oklahoma City
Dr. Maryam Shambayati, D.o, D.O
Pediatrics — Payments: $187,302
Osman Khan, M.d, M.D
Pediatrics — Payments: $134,738
Joe Ghata, Md, MD
Pediatrics — Payments: $24,965
Stuart Schrader, D.o, D.O
Pediatrics — Payments: $14,020
Scott Melson, Md, MD
Pediatrics — Payments: $10,932
Alisha Solomon, Md, MD
Pediatrics — Payments: $9,605